Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GelPOINT Mini Advanced Access Platform

K-Number: K191866 · 2020-04-29

Decision Date2020-04-29
Product CodeGCJ
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

GelPOINT Mini Advanced Access Platform is a medical device manufactured by Applied Medical. It received FDA 510(k) clearance on 2020-04-29 under approval number K191866. The device is classified under product code GCJ. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GelPOINT Mini Advanced Access Platform?

GelPOINT Mini Advanced Access Platform is a medical device that received FDA 510(k) clearance on 2020-04-29. It is manufactured by Applied Medical. The 510(k) number is K191866.

When was GelPOINT Mini Advanced Access Platform approved by the FDA?

GelPOINT Mini Advanced Access Platform received FDA 510(k) clearance on 2020-04-29, under approval number K191866.

What company makes GelPOINT Mini Advanced Access Platform?

GelPOINT Mini Advanced Access Platform is manufactured by Applied Medical.

What is the FDA product code for GelPOINT Mini Advanced Access Platform?

The FDA product code for GelPOINT Mini Advanced Access Platform is GCJ.

Related Clinical Trials

Related PubMed Literature

Other Devices by Applied Medical

Related Devices (Code: GCJ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.